Press Release
HALF-YEAR REPORT ON THE NANOBIOTIX LIQUIDITY CONTRACT WITH GILBERT DUPONT
Paris, France ; Cambridge, Massachusetts (USA) ; July 13, 2022 -NANOBIOTIX(Euronext : NANO --
NASDAQ: NBTX - the ''Company"), a late-clinical stage biotechnology company pioneering physics-based
approaches to expand treatment possibilities for patients with cancer, today issued the Half-Year report on its
liquidity contract with Gilbert Dupont.
As of June 30, 2022, the following resources appeared on the liquidity account:
- Number of shares: 25,706
- Cash balance: € 60,051.07
During the 1st Half of 2022, a total of:
Buy side | Traded volume: | €1,883,900.28 | 2,285 transactions |
306,341 shares | |||
Sell side | Traded volume: | €1,846,535.38 | 2,127 transactions |
296,091 shares |
As of December 31, 2021, the following resources appeared on the liquidity account:
- Number of shares: 15,456
- Cash balance: € 97,415.97
Upon signing of the liquidity contract the following assets were made available:
- Number of shares: 0
- Cash balance: € 300,000.00
The implementation of this half-year report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
About NANOBIOTIX
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company is leveraging its proprietary nanoparticle platform, including its lead product candidate, radiotherapy activated NBTXR3, to develop a pipeline of therapeutic options designed to enhance local and systemic control of solid tumors with an initial focus on the treatment of head and neck cancers.
For more information about Nanobiotix, visit us at www.nanobiotix.comor follow us on LinkedInand Twitter
Contacts
Nanobiotix
Communications Department | Investor Relations Department |
Brandon Owens | Kate McNeil |
VP, Communications | SVP, Investor Relations |
+1 (617) 852-4835 | +1 (609) 678-7388 |
contact@nanobiotix.com | investors@nanobiotix.com |
Media Relations
FR - Ulysse Communication
Pierre-Louis Germain
- 33 (0) 6 64 79 97 51plgermain@ulysse- communication.com
Appendix | |||||||
Buy Side | Sell Side | ||||||
Number of | Number of | Traded | Number of | Number of | Traded volume | ||
executions | shares | volume in | executions | shares | in | ||
EUR | EUR | ||||||
TOTAL | 2 285 | 306 341 | 1 883 900,28 | 2 127 | 296 091 | 1 846 535,38 | |
03/01/2022 | 0 | 0 | 0 | 21 | 2360 | 17493,97 | |
04/01/2022 | 30 | 4753 | 35173,63 | 6 | 716 | 5470,24 | |
05/01/2022 | 0 | 2100 | 14984,76 | 0 | 3315 | 23778,83 | |
06/01/2022 | 2 | 420 | 3015,6 | 37 | 5679 | 44096,87 | |
07/01/2022 | 12 | 869 | 7194,89 | 0 | 0 | 0 | |
10/01/2022 | 30 | 4602 | 36377,89 | 24 | 1948 | 15592,77 | |
11/01/2022 | 6 | 1332 | 10283,31 | 20 | 2639 | 20708,5 | |
12/01/2022 | 24 | 2181 | 17436,66 | 40 | 2667 | 21531,22 | |
13/01/2022 | 20 | 3301 | 26441,67 | 28 | 3268 | 26262,96 | |
14/01/2022 | 29 | 3580 | 28429,14 | 15 | 2143 | 17134,14 | |
17/01/2022 | 9 | 1201 | 9562,96 | 22 | 2923 | 23399,2 | |
18/01/2022 | 20 | 2919 | 23085,2 | 7 | 1315 | 10416,25 | |
19/01/2022 | 0 | 2905 | 22440,25 | 0 | 6021 | 47191,39 | |
20/01/2022 | 45 | 6542 | 51125,08 | 39 | 6633 | 52169,21 | |
21/01/2022 | 0 | 4402 | 34010,29 | 0 | 0 | 0 | |
24/01/2022 | 0 | 1809 | 12956,96 | 0 | 450 | 3318,75 | |
25/01/2022 | 8 | 1150 | 7789,3 | 18 | 2810 | 19175,72 | |
26/01/2022 | 11 | 765 | 5206,82 | 15 | 2306 | 15981,96 | |
27/01/2022 | 0 | 1164 | 8376,73 | 0 | 4044 | 28807,03 | |
28/01/2022 | 35 | 7856 | 54686,4 | 16 | 2937 | 20504,37 | |
31/01/2022 | 17 | 3256 | 22758,14 | 40 | 5682 | 40163,22 | |
01/02/2022 | 0 | 2328 | 16191,94 | 0 | 2614 | 18442,55 | |
02/02/2022 | 0 | 0 | 0 | 26 | 3893 | 28882,56 | |
03/02/2022 | 25 | 2002 | 15008,19 | 0 | 0 | 0 | |
04/02/2022 | 28 | 2825 | 20870,82 | 12 | 1752 | 13038,38 | |
07/02/2022 | 25 | 2282 | 16951,61 | 18 | 2735 | 20459,17 | |
08/02/2022 | 19 | 2626 | 19552,93 | 28 | 2355 | 17646,96 | |
09/02/2022 | 0 | 1130 | 8388,89 | 0 | 1409 | 10550,03 | |
10/02/2022 | 21 | 4011 | 30677,33 | 24 | 3728 | 28587,8 | |
11/02/2022 | 23 | 4045 | 30890,05 | 17 | 4732 | 36336,55 | |
14/02/2022 | 0 | 6691 | 49974,41 | 0 | 5776 | 43559,13 | |
15/02/2022 | 20 | 2472 | 18737,27 | 21 | 4703 | 36150,55 | |
16/02/2022 | 28 | 3545 | 27412,07 | 34 | 2710 | 21038 | |
17/02/2022 | 22 | 2835 | 21832,62 | 13 | 2129 | 16514,44 | |
18/02/2022 | 22 | 3707 | 28062,36 | 1 | 1 | 7,68 | |
21/02/2022 | 36 | 4045 | 29154,34 | 4 | 550 | 4089,53 | |
22/02/2022 | 21 | 3367 | 22882,13 | 15 | 2451 | 16898,91 | |
23/02/2022 | 29 | 5689 | 38694,87 | 21 | 2940 | 20181,63 | |
24/02/2022 | 26 | 3184 | 20432,05 | 23 | 3991 | 25924,74 | |
25/02/2022 | 3 | 301 | 2010,62 | 37 | 5187 | 35355,63 | |
28/02/2022 | 16 | 1800 | 12132 | 20 | 2864 | 19767,9 | |
01/03/2022 | 51 | 4724 | 32079,27 | 0 | 0 | 0 | |
02/03/2022 | 43 | 3055 | 19923,18 | 23 | 2828 | 18626,34 | |
03/03/2022 | 47 | 5304 | 34617,62 | 21 | 3505 | 23263,39 | |
04/03/2022 | 36 | 4389 | 27518,15 | 5 | 665 | 4262,65 | |
07/03/2022 | 52 | 5548 | 31326,23 | 42 | 5387 | 30655,26 | |
08/03/2022 | 28 | 2369 | 13157,9 | 26 | 2311 | 13083,73 | |
09/03/2022 | 21 | 1517 | 9290,26 | 53 | 6168 | 37323,8 | |
10/03/2022 | 58 | 4261 | 26428 | 46 | 4244 | 26509,72 | |
11/03/2022 | 12 | 2651 | 16604,01 | 59 | 4804 | 30249,83 | |
14/03/2022 | 4 | 1111 | 7042,85 | 10 | 1001 | 6473,27 |
15/03/2022 | 25 | 3902 | 24260,69 | 0 | 0 | 0 |
16/03/2022 | 0 | 100 | 625 | 0 | 2492 | 15833,42 |
17/03/2022 | 3 | 600 | 3802,5 | 64 | 6644 | 42855,13 |
18/03/2022 | 12 | 1217 | 8068,59 | 19 | 1785 | 11849,9 |
21/03/2022 | 19 | 1690 | 11159,58 | 10 | 1300 | 8816,99 |
22/03/2022 | 10 | 1448 | 9491,06 | 22 | 2603 | 17308,91 |
23/03/2022 | 5 | 908 | 6070,34 | 22 | 2273 | 15363,66 |
24/03/2022 | 0 | 4986 | 32829,82 | 0 | 0 | 0 |
25/03/2022 | 18 | 2364 | 15098,87 | 14 | 2620 | 16910,79 |
28/03/2022 | 2 | 201 | 1282,38 | 15 | 1336 | 8596,09 |
29/03/2022 | 6 | 110 | 709,8 | 38 | 3847 | 25423,28 |
30/03/2022 | 17 | 2305 | 15060,64 | 12 | 2058 | 13809,59 |
31/03/2022 | 21 | 2016 | 13655,17 | 8 | 1020 | 6995,87 |
01/04/2022 | 28 | 2881 | 18964,18 | 30 | 2530 | 16704,83 |
04/04/2022 | 0 | 200 | 1304 | 0 | 1695 | 11250,9 |
05/04/2022 | 14 | 2151 | 14485,91 | 24 | 3009 | 20886,97 |
06/04/2022 | 14 | 1390 | 8999,83 | 7 | 772 | 5160,97 |
07/04/2022 | 23 | 2645 | 16577,01 | 12 | 1848 | 11719,46 |
08/04/2022 | 19 | 1853 | 11678,53 | 20 | 1928 | 12173,97 |
11/04/2022 | 21 | 3003 | 18642,62 | 13 | 2011 | 12559,9 |
12/04/2022 | 0 | 1083 | 6822,9 | 0 | 2086 | 13385,03 |
13/04/2022 | 14 | 1626 | 9988,5 | 0 | 0 | 0 |
14/04/2022 | 23 | 2925 | 17683,38 | 21 | 1890 | 11508,97 |
19/04/2022 | 19 | 2286 | 13651,76 | 17 | 2202 | 13232,04 |
20/04/2022 | 19 | 1863 | 11130,87 | 20 | 2174 | 13091,39 |
21/04/2022 | 18 | 2029 | 12279,71 | 36 | 2068 | 12694 |
22/04/2022 | 26 | 3220 | 19101,68 | 10 | 670 | 4016,38 |
25/04/2022 | 17 | 983 | 5800,19 | 12 | 1315 | 7753,11 |
26/04/2022 | 21 | 2227 | 13125,49 | 4 | 174 | 1035,06 |
27/04/2022 | 28 | 2246 | 12878,34 | 1 | 110 | 630,3 |
28/04/2022 | 13 | 924 | 5216,72 | 11 | 838 | 4767,21 |
29/04/2022 | 16 | 1436 | 8128,05 | 13 | 1617 | 9298,72 |
02/05/2022 | 15 | 1175 | 6597,39 | 9 | 979 | 5483,28 |
03/05/2022 | 10 | 1020 | 5846,84 | 17 | 1237 | 7085,54 |
04/05/2022 | 12 | 1448 | 8194,38 | 0 | 0 | 0 |
05/05/2022 | 24 | 2681 | 14846,31 | 24 | 2615 | 14681,92 |
06/05/2022 | 16 | 1722 | 9388,34 | 16 | 1719 | 9376,97 |
09/05/2022 | 26 | 1841 | 9738,34 | 4 | 500 | 2689 |
10/05/2022 | 15 | 2165 | 11029,59 | 14 | 758 | 3888,99 |
11/05/2022 | 16 | 3256 | 16420,33 | 19 | 1971 | 10108,27 |
12/05/2022 | 24 | 2647 | 13043,89 | 17 | 1757 | 8684,15 |
13/05/2022 | 2 | 152 | 755,44 | 19 | 3470 | 17422,52 |
16/05/2022 | 21 | 2949 | 14840,55 | 8 | 1880 | 9512,24 |
17/05/2022 | 2 | 334 | 1686,7 | 18 | 3987 | 20847,23 |
18/05/2022 | 16 | 1320 | 6864 | 14 | 1224 | 6453,17 |
19/05/2022 | 12 | 2129 | 10817,66 | 33 | 4158 | 21714,74 |
20/05/2022 | 26 | 3074 | 16019,54 | 13 | 1198 | 6392,29 |
23/05/2022 | 7 | 516 | 2665,66 | 9 | 1323 | 6954,75 |
24/05/2022 | 36 | 2287 | 11526,71 | 4 | 105 | 513,05 |
25/05/2022 | 11 | 1109 | 5324,53 | 2 | 9 | 44,01 |
26/05/2022 | 7 | 1177 | 5547,55 | 31 | 2167 | 10433,67 |
27/05/2022 | 11 | 1157 | 5665,71 | 30 | 3100 | 15382,51 |
30/05/2022 | 8 | 1300 | 6588,01 | 23 | 3033 | 15540,79 |
31/05/2022 | 60 | 7767 | 38824,13 | 59 | 7415 | 37150,63 |
01/06/2022 | 24 | 3224 | 15558,7 | 28 | 3107 | 15122,08 |
02/06/2022 | 51 | 4409 | 20724,5 | 33 | 3493 | 16457,62 |
03/06/2022 | 30 | 3034 | 14086,86 | 34 | 3029 | 14061,53 |
06/06/2022 | 7 | 1500 | 7197,45 | 31 | 4500 | 21740,4 |
07/06/2022 | 15 | 1564 | 7274,63 | 0 | 0 | 0 |
08/06/2022 | 14 | 1764 | 7928,65 | 8 | 1530 | 6910,09 |
09/06/2022 | 32 | 3004 | 13233,52 | 14 | 1668 | 7459,96 |
10/06/2022 | 36 | 3004 | 12370,77 | 21 | 2794 | 11585,6 |
13/06/2022 | 24 | 3013 | 11769,38 | 7 | 1087 | 4251,69 |
14/06/2022 | 13 | 1723 | 6322,2 | 7 | 1578 | 5862,74 |
15/06/2022 | 19 | 1999 | 7261,77 | 18 | 2245 | 8237,35 |
16/06/2022 | 26 | 2814 | 10051,05 | 22 | 2423 | 8754,54 |
17/06/2022 | 26 | 3188 | 11460,86 | 32 | 3431 | 12320,72 |
20/06/2022 | 0 | 0 | 0 | 0 | 2532 | 9668,7 |
21/06/2022 | 0 | 2238 | 8510,44 | 0 | 982 | 3908,16 |
22/06/2022 | 0 | 2665 | 9701,4 | 0 | 2257 | 8295,83 |
23/06/2022 | 30 | 2918 | 10297,62 | 8 | 1555 | 5552,28 |
24/06/2022 | 2 | 390 | 1390,9 | 19 | 2996 | 11018,69 |
27/06/2022 | 12 | 2293 | 8454,29 | 19 | 2262 | 8510,78 |
28/06/2022 | 26 | 5052 | 18153,35 | 17 | 3487 | 12627,82 |
29/06/2022 | 16 | 1831 | 6346,43 | 1 | 200 | 696 |
30/06/2022 | 20 | 1749 | 5820,15 | 3 | 126 | 423,51 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Nanobiotix SA published this content on 13 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 July 2022 23:13:01 UTC.